#
Aspirin and Dipyridamole Capsules
  • Professionals
  • FDA PI

Aspirin and Dipyridamole Capsules

Dosage form: capsule, extended release
Drug class:Platelet aggregation inhibitors

Medically reviewed by Drugs.com. Last updated on Oct 1, 2021.

INDICATIONS & USAGE

Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

DOSAGE & ADMINISTRATION

Aspirin and Extended-Release Dipyridamole Capsules are not interchangeable with the individual components of aspirin and dipyridamole tablets.

The recommended dose of Aspirin and Extended-Release Dipyridamole Capsules is one capsule given orally twice daily, one in the morning and one in the evening. Swallow capsules whole without chewing. Aspirin and Extended-Release Dipyridamole Capsules can be administered with or without food.

Alternative Regimen in Case of Intolerable Headaches

In the event of intolerable headaches during initial treatment, switch to one capsule at bedtime and low-dose aspirin in the morning. Because there are no outcome data with this regimen and headaches become less of a problem as treatment continues, patients should return to the usual regimen as soon as possible, usually within one week.

DOSAGE FORMS & STRENGTHS

25 mg/200 mg capsules are imprinted in black with ‘PAR’ on the cap and ‘730’ on the body, containing yellow colored extended-release pellets incorporating dipyridamole and a white to off white, film coated, circular bi-convex tablet incorporating immediate-release aspirin.

Contraindications

Hypersensitivity

Aspirin and extended-release dipyridamole is contraindicated in patients with known hypersensitivity to any of the product components.

CONTACT INFORMATION

LINKS

MEDICAL DEPARTMENTS

Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram